Cytokinetics CYTK
NASDAQ CYTK
$65.91 +0.27 (+0.41%)
At close: Sep 30, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) Tax Provisions (2010)

Updated

Cytokinetics' Tax Provisions came in at -$176,000 for FY2010, compared with $150,000 in FY2009.

Analysis

Cytokinetics (CYTK) Tax Provisions (2010) Analysis & Trends

  • Per Business Quant, earlier years put Tax Provisions at $150,000 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Cytokinetics 9.16 Bn 5.33 Bn 25.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 -176,000.00
API Access

Cytokinetics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=CYTK&period=max&api_key=YOUR_API_KEY